Dosing and Switching Strategies for Paliperidone Palmitate 3-Month Formulation in Patients with Schizophrenia Based on Population Pharmacokinetic Modeling and Simulation, and Clinical Trial Data
Crossref DOI link: https://doi.org/10.1007/s40263-017-0416-1
Published Online: 2017-03-04
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Magnusson, Mats O.
Samtani, Mahesh N.
Plan, Elodie L.
Jonsson, E. Niclas
Rossenu, Stefaan
Vermeulen, An
Russu, Alberto
License valid from 2017-03-04